IFNG and Alzheimer disease: A key finding in this experiment is that IFN-γ-mediated downregulation of NRF2 promotes ROS accumulation and drives the transition of neuroprotective microglia to a neurodegenerative phenotype via the classical NF-κB pathway, leading to neurodegeneration in the AD mini-brains.